Nearly 15 years after its controversial drug trial on 200 children with meningitis in Nigeria, Pfizer Inc. and all plaintiffs in the cases related to the trial announced today that they have reached a global settlement.

In a joint statement, the parties said, “Under the terms of the settlement agreement, the plaintiffs will join the ongoing Healthcare/Meningitis Trust Fund process, which is being managed by an independent Board of Trustees in Kano, Nigeria.